Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 113,388 shares at $80.80 ($9.2M) on 2019-11-13, disclosed to the SEC on 2019-11-15.
Open-market sale of $9.2M NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.72 | 13,668 | $1.1M | 12.0% |
| 2 | $80.72 | 13,668 | $1.1M | 12.0% |
| 3 | $80.78 | 7,458 | $602K | 6.5% |
| 4 | $80.79 | 7,458 | $603K | 6.5% |
| 5 | $80.80 | 7,542 | $609K | 6.6% |
| 6 | $80.80 | 7,542 |
| $609K |
| 6.6% |
| 7 | $81.13 | 6,332 | $514K | 5.6% |
| 8 | $81.13 | 6,332 | $514K | 5.6% |
| 9 | $81.16 | 2,458 | $199K | 2.2% |
| 10 | $81.16 | 2,542 | $206K | 2.2% |
| 11 | $81.16 | 2,458 | $199K | 2.2% |
| 12 | $81.16 | 2,542 | $206K | 2.2% |
| 13 | $80.68 | 600 | $48K | 0.5% |
| 14 | $80.68 | 600 | $48K | 0.5% |
| 15 | $80.78 | 2,000 | $162K | 1.8% |
| 16 | $80.96 | 500 | $40K | 0.4% |
| 17 | $80.96 | 500 | $40K | 0.4% |
| 18 | $81.66 | 2,805 | $229K | 2.5% |
| 19 | $81.66 | 2,805 | $229K | 2.5% |
| 20 | $81.67 | 10,800 | $882K | 9.6% |
| 21 | $81.80 | 1,403 | $115K | 1.2% |
| 22 | $81.80 | 1,403 | $115K | 1.2% |
| 23 | $82.50 | 1,764 | $146K | 1.6% |
| 24 | $82.53 | 7,200 | $594K | 6.5% |
| 25 | $82.62 | 504 | $42K | 0.5% |
| 26 | $82.62 | 504 | $42K | 0.5% |
| Total | $81.15 avg | 113,388 | $9.2M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |